✦ LIBER ✦

Sentinel lymph node biopsy for localised ductal carcinoma in situ?

✍ Scribed by P. Veronesi; M. Intra; A.R. Vento; P. Naninato; P. Caldarella; G. Paganelli; G. Viale

Book ID: 113506702
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 115 KB
Volume: 14
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2005.08.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ductal carcinoma in situ: Value of senti

Ductal carcinoma in situ: Value of sentinel lymph node biopsy

✍ Rita Sakr; Emmanuel Barranger; Martine Antoine; Herve Prugnolle; Emile Daraï; Se 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Sentinel Lymph Node Biopsy in the Manage

Sentinel Lymph Node Biopsy in the Management of Ductal Carcinoma In Situ

✍ JoAnne Zujewski; Jennifer Eng-Wong 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 484 KB

The role of sentinel lymph node biopsy i

The role of sentinel lymph node biopsy in ductal carcinoma in situ

✍ C.J. Moran; M.R. Kell; M.J. Kerin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Sentinel lymph node biopsy in ductal car

Sentinel lymph node biopsy in ductal carcinoma in situ diagnosed by core-needle biopsy

✍ P. Meijnen; Oldenburg; J.L. Peterse; E.J.T. Rutgers 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Core biopsy diagnosis of ductal carcinom

Core biopsy diagnosis of ductal carcinoma in situ: An indication for sentinel lymph node biopsy

✍ Maj Elizabeth A. Mittendorf; Cletus A. Arciero; Veronica Gutchell; Jeff Hooke; C 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Occult “micrometastases” in ductal carci

Occult “micrometastases” in ductal carcinoma in situ : Investigative implications for sentinel lymph node biopsy.

✍ Donald L. Weaver 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

Sentinel lymph node biopsy is frequently associated with identification of micrometastatic tumor deposits. The clinical relevance of identifying micrometastases in breast cancer must be evaluated in the statistical context of the lymph node evaluation strategy and the likelihood of missing a metasta